Antistaphylococcal Activity of Dalbavancin, an Experimental Glycopeptide
Dalbavancin, tested against 146 staphylococci, was more potent than other drugs tested, with an MIC at which 50% of staphylococci were inhibited of 0.03 μg/ml and an MIC at which 90% of staphylococci were inhibited of 0.06 μg/ml by microdilution. For all strains, MICs of vancomycin, linezolid, ranbe...
Sparad:
| I publikationen: | Antimicrob Agents Chemother |
|---|---|
| Huvudupphov: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
American Society for Microbiology (ASM)
2005
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC547276/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15673763/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.49.2.770-772.2005 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|